(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

LUX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

LUX

ST13

US500000079226449

Class

5, 10

Filing

79226449

Registration

5548009

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

37

Latest update

07/02/2026

Trademark type

Word

Nice classes

5, 10

Filing date

11/15/2017

Registration date

08/28/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/14/2025

Last transaction

07/02/2026

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

4

Owner type

25

Owner location

CH

Examiner

EINSTEIN, MATTHEW T

Law office

M60

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

BIOTRONIK AG

Representatives

GABRIELLE S. ROTH SUGHRUE MION, PLLC

Technical classification

Nice Classes

Class 5Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Chemical and pharmaceutical preparations for medical purposesdrug preparations for treating coronary artery diseasesvascular diseasespreventing neointimal proliferation after vessel dilatation; chemical and pharmaceutical drug delivery preparations in the form of coatings for medical devices and balloons that facilitate the delivery of pharmaceuticals; chemical preparations for pharmaceutical purposesdrug preparations for treating coronary artery diseasesvascular diseasespreventing neointimal proliferation after vessel dilatation; pharmaceutical preparations for treating coronary artery diseasesvascular diseasespreventing neointimal proliferation after vessel dilatation; drugs for medical purposesdrugs for treating coronary artery diseasesvascular diseasespreventing neointimal proliferation after vessel dilatation; excipientsdrug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals for use in drug eluting balloons

Class 10

Medical apparatus and instrumentscatheterscatheters for percutaneous coronary intervention (PCI)catheters for percutaneous transluminal coronary angioplasty (PTCA catheters)catheters for percutaneous transluminal angioplasty (PTA catheters)catheters for balloon dilatation; medical apparatusballoons for vessel dilatationballoons for treating coronary artery diseasesvascular diseasespreventing neointimal proliferation after vessel dilatationcoronary and peripheral balloon cathetersdrug eluting balloonsdrug releasing balloonsdrug coated balloonsstents and drug eluting stents

Publications

History of USPTO decisions and trademark events.

37 publications found

INNT

TOTAL INVALIDATION PROCESSED BY THE IB

07/02/2026

INTS

TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

06/12/2026

INPC

INVALIDATION PROCESSED

06/12/2026

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

11/14/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

08/07/2025

C71T

CANCELLED SECTION 71

03/14/2025

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

08/28/2023

NREP

NEW REPRESENTATIVE AT IB RECEIVED

09/18/2021

NREP

NEW REPRESENTATIVE AT IB RECEIVED

06/05/2021

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

12/28/2018

FICS

FINAL DISPOSITION NOTICE SENT TO IB

12/08/2018

FIMP

FINAL DISPOSITION PROCESSED

12/08/2018

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

11/28/2018

R.PR

REGISTERED-PRINCIPAL REGISTER

08/28/2018

NREP

NEW REPRESENTATIVE AT IB RECEIVED

08/24/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/12/2018

PUBO

PUBLISHED FOR OPPOSITION

06/12/2018

GPNX

NOTIFICATION PROCESSED BY IB

06/08/2018

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

05/23/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/23/2018

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

05/23/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/07/2018

XAEC

EXAMINER'S AMENDMENT ENTERED

05/07/2018

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

05/07/2018

GNEA

EXAMINERS AMENDMENT E-MAILED

05/07/2018

CNEA

EXAMINERS AMENDMENT -WRITTEN

05/07/2018

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/02/2018

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/02/2018

RFNT

REFUSAL PROCESSED BY IB

03/24/2018

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

03/07/2018

RFRR

REFUSAL PROCESSED BY MPU

03/07/2018

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

03/01/2018

CNRT

NON-FINAL ACTION WRITTEN

02/28/2018

DOCK

ASSIGNED TO EXAMINER

02/27/2018

MAFR

APPLICATION FILING RECEIPT MAILED

02/13/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/09/2018

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

02/08/2018

Continuous trademark protection

Get notified about every new filing that threatens LUX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.